ENANTA PHARMACEUTICALS INC
ENTA·29251M106·US·Common Stock·Healthcare - Biotechnology-13D/G
ENTA (ENANTA PHARMACEUTICALS INC) is held by 78 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($47.7M), BlackRock, Inc. ($39.2M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($36.3M). Net institutional sentiment: Mixed.
78
Holders
Avg rating(19 Elite)
$241.5M
Total Value
59% (87)
Fund Consensus
46 buying - 32 selling
Who's Trading
ActivistDTDeep Track Capital, LP6.8%Feb 13, 2026
ActivistFAFarallon Capital Partners, L.P.1.8%Feb 5, 2026
ActivistICIntegrated Core Strategies (US) LLC2.3%Jan 20, 2026
InsiderLRLuly Jay R.Sell $67KDec 5, 2025
InsiderOSOr Yat SunSell $34KDec 5, 2025
InsiderTITrout Harry R. IIISell $8KDec 5, 2025
InsiderCSCapps Kathleen S.Sell $5KDec 5, 2025
13F: Insider & Congress:
Showing 1-20 of 87
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer